Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SP01A Monotherapy in HIV-Infected Patients
NCT00113412Phase 2Unknown
- Sponsor
- Samaritan Pharmaceuticals, Inc.
- Start
- May 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of procaine in human immunodeficiency virus infection (HIV) (4 arms), sponsored by Samaritan Pharmaceuticals, Inc. Primary endpoints: Reduction in viral load (log10) at 10 days and Safety assessment at 10 days. Status: unknown.
02
Drugs
procaine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00113412.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00113412.